Opinion: CVS’ drug-price plan lets pharma off too easy

CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
CVS HEALTH CORP. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients such as insurers. / BLOOMBERG NEWS FILE PHOTO/CHRISTOPHER LEE
NEW YORK - The pharmacy benefit management business is under attack. And these middlemen of the arcane United States drug-pricing system are preparing their defenses. PBM giant CVS Health Corp. released a report last week pushing back on accusations that the company and its peers reap excessive profits as they negotiate drug prices on behalf of clients…

Want More?

Register or subscribe with
Providence Business News to continue reading.

Register Now

Subscribe for $1

Already registered? Login to access more articles.

*Registered users get access to a limited number of free articles every month.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -